Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian Province: A population-based analysis

Journal of Oncology Practice

Volumn 8, Issue 4, 2012, Pages 253-259

  Rayson, Daniel ^a   Urquhart, Robin ^a   Cox, Martha ^a   Grunfeld, Eva ^a   Porter, Geoff ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER STAGING; CLINICAL PRACTICE; COLON CANCER; COLORECTAL CANCER; CONSULTATION; FEMALE; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RECTUM CANCER; SOCIAL ISOLATION; TERTIARY HEALTH CARE;

AGED; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DELIVERY OF HEALTH CARE; FEMALE; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; MALE; MIDDLE AGED; NOVA SCOTIA;

EID: 84869880282     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2012.000578     Document Type: Article

References (47)

1. Siegel R, Ward E, Brawley O, et al: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212-236, 2011
2. Canadian Cancer Society: Canadian Cancer Statistics 2010. Toronto, Canada, Canadian Cancer Society, 2010
3. Cunningham D, Atkin W, Lenz HJ, et al: Colorectal cancer. Lancet 375:1030-1047, 2010
4. Saltz LB, Minsky B: Adjuvant therapy of cancers of the colon and rectum. Surg Clin North Am 82:1035-1058, 2002 (Pubitemid 35463083)
5. Jonker DJ, Spithoff K, Maroun J: Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Adjuvant systemic chemotherapy for stage II and III colon cancer after complete resection: An updated practice guideline. Clin Oncol (R Coll Radiol) 23:314-322, 2011
6. NIH Consensus Conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444-1150, 1990
7. O'Connell MJ, Mailliard JA, Kahn MJ, et al: Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 15:246-250, 1997 (Pubitemid 27020580)
8. O'Connell MJ, Martenson JA, Wieand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502-507, 1994
9. Wirtzfeld DA, Mikula L, Gryfe R, et al: Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: Experience in 2 Canadian provinces. Can J Surg 52:92-97, 2009
10. Van Cutsem E, Costa F: Progress in the adjuvant treatment of colon cancer; has it influenced clinical practice? JAMA 294:2758-2760, 2005
11. American Joint Committee on Cancer Collaborative Stage Work Group: Collaborative Stage Data Collection System Coding Instructions, version 02.00.00 [Incorporates updates through January 1, 2010]. Chicago, IL, American Joint Committee on Cancer, 2010
12. Urquhart R, Grunfeld E: Building tools to measure and improve access to and quality of colorectal cancer care in Nova Scotia. Can J Gastroenterol 24:91A, 2010 (suppl SA)
13. Elixhauser A, Steiner C, Harris DR, et al: Comorbidity measures for use with administrative data. Med Care 36:8-27, 1998 (Pubitemid 128456396)
14. Statistics Canada: Postal code conversion file plus (PCCF+), version 4J, with postal codes through September 2006. Ottawa, Canada, Statistics Canada, 2011
15. McNiven C, Puderer H, Janes D: Census Metropolitan Area and Census Agglomeration Influenced Zones (MIZ): A Description of the Methodology (Geography Working Paper Series No. 2000-2). Ottawa, Canada, Geography Division, Statistics Canada, 2000
16. Pampalon R, Raymond G: A deprivation index for health and welfare planning in Quebec. Chronic Dis Can 21:104-113, 2000
17. Canadian Partnership Against Cancer: The System Performance Initiative: A First Year Report. Toronto, Canada, Canadian Partnership Against Cancer, 2009
18. Malin JL, Kahn KL, Adams J, et al: Validity of cancer registry data for measuring quality of breast cancer care. J Natl Cancer Inst 94:835-844, 2002 (Pubitemid 34705055)
19. Bickell NA, Chassin MR: Determining the quality of breast cancer care: Do tumor registries measure up? Ann Intern Med 132:705-710, 2000 (Pubitemid 30244169)
20. Urquhart R, Rayson D, Porter GA, et al: Quantifying limitations in chemotherapy data in administrative health databases: Implications for measuring the quality of colorectal cancer care. Health Pol 7:32-40, 2011
21. Jessup JM, Stewart A, Greene FL, et al: Adjuvant chemotherapy for stage III colon cancer: Implications of race/ethnicity, age, and differentiation. JAMA 294: 2703-2711, 2005 (Pubitemid 41770099)
22. Mitry E, Bouvier AM, Esteve J, et al: Improvements in colorectal cancer survival: A population-based study. Eur J Cancer 41:2297-2303, 2005 (Pubitemid 41415606)
23. Cronin DP, Harlan LC, Potosky AL, et al: Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol 101:2308-2318, 2006 (Pubitemid 44477559)
24. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al: Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 21:1293-1300, 2003 (Pubitemid 46606406)
25. Lima IS, Yasui Y, Scarfe A, et al: Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada. Cancer 117:3833-3840, 2011
26. Renouf D, Kennecke H, Gill S: Trends in chemotherapy utilization for colorectal cancer. Clin Colorectal Cancer 7:386-389, 2008
27. Cree M, Tonita J, Turner D, et al: Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004. Clin Colorectal Cancer 8:141-145, 2009
28. Sargent DJ, Goldberg RM, Jacobson SD, et al: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345: 1091-1097, 2001
29. Goldberg RM, Tabah-Fisch I, Bleiberg H, et al: Pooled analysis of safety and efficacy of oxaliplatin plus fluouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol 24:4085-4091, 2006 (Pubitemid 46622283)
30. Zuckerman IH, Rapp T, Onukwugha E, et al: Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with stage III colon cancer. J Am Geriatr Soc 57:1403-1410, 2009
31. Kahn KL, Adams JL, Weeks JC, et al: Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA 303:1037-1045, 2010
32. Rayson D, Saint-Jacques N, Younis T, et al: Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/2004. CMAJ 176:327-332, 2007
33. Saint-Jacques N, Rayson D, Al-Fayea T, et al: Waiting times in early-stage non-small cell lung cancer (NSCLC). J Thorac Oncol 3:865-870, 2008
34. Hershman D, Hall MJ, Wang X, et al: Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer 107:2581-2588, 2006 (Pubitemid 44845611)
35. Ahmed S, Ahmad I, Zhu T, et al: Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: A population-based study. Dis Colon Rectum 53:1432-1438, 2010
36. Bayraktar UD, Chen E, Bayraktar S, et al: Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma? Cancer 117:2364-2370, 2011
37. Moertel CG, Fleming TR, Macdonald JS, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon cancer. N Engl J Med 322:352-358, 1990 (Pubitemid 20042739)
38. André T, Boni C, Mounedji-Boudiaf L, et al: Oxaliplatin, fluorouracil and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351, 2004 (Pubitemid 38702845)
39. Twelves C, Wong A, Nowacki MP, et al: Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 352:2696-2704, 2005 (Pubitemid 41007824)
40. British Columbia Cancer Agency: Gastrointestinal. www.bccancer.bc.ca/HPI/ CancerManagementGuidelines/Gastrointestinal/default.htm
41. Des Guetz G, Nicolas P, Perret GY, et al: Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur J Cancer 46:1049-1055, 2010
42. Biagi JJ, Raphael MJ, Mackillop WJ, et al: Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: A systematic review and meta-analysis. JAMA 305:2335-2342, 2011
43. Davidoff AJ, Rapp T, Onukwugha E, et al: Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients, the role of the medical oncologist evaluation. Med Care 47:1229-1236, 2009
44. Luo R, Giordano SH, Freeman JL, et al: Referral to medical oncology: A crucial step in the treatment of older patients with stage III colon cancer. Oncologist 11:1025-1033, 2006 (Pubitemid 44564812)
45. Rogers SO Jr, Ayanian JZ, Ko CY, et al: Surgeons' volume of colorectal cancer procedures and collaborative decision-making about adjuvant therapies. Ann Surg 250:895-900, 2009
46. Elkin EB, Kim SH, Casper ES, et al: Desire for information and involvement in treatment decisions: Elderly cancer patients' preferences and their physicians' perceptions. J Clin Oncol 25:5275-5280, 2007 (Pubitemid 350232261)
47. Abrams TA, Brightly R, Mao J, et al: Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer. J Clin Oncol 29:3255-3262, 2011